Canine Brucellosis

Introduction

Canine brucellosis is a contagious bacterial disease that significantly impacts dog breeding and reproductive health. First identified in 1966 with the isolation of Brucella canis, this infection remains a major concern in kennels worldwide due to its economic consequences and diagnostic challenges.

The disease is globally distributed, with reported cases across the Americas, Europe, Asia, and Africa. Despite its wide prevalence, accurate diagnosis remains difficult because infected dogs may show no clear clinical signs, and laboratory results can vary. This often complicates disease management and control in breeding populations.

Etiology of Canine Brucellosis

The primary causative agent is Brucella canis, a Gram-negative bacterium that specifically affects dogs. Unlike other Brucella species (such as B. abortus, B. melitensis, and B. suis), which occasionally infect dogs, B. canis is the main pathogen of epidemiological importance.

 characteristics:

  • Gram-negative coccobacillus
  • Grows on standard laboratory media
  • Does not require special atmospheric conditions
  • Infects all dog breeds
  • Can occasionally infect humans (zoonotic potential)

Transmission

Canine brucellosis spreads primarily through:

  • Reproductive fluids (semen, vaginal secretions)
  • Aborted materials (placenta, fetus, uterine discharge)
  • Urine, especially from infected males
  • Milk, although its role is debated
  • Direct contact with contaminated environments or equipment

Transmission routes include:

  • Venereal (mating)
  • Oral (ingestion of contaminated material)
  • Environmental exposure

The bacteria can persist in biological fluids at high concentrations, making infected animals a major source of contamination.

Pathogenesis

The infection enters the body through:

  • Genital mucosa
  • Oral or nasal routes
  • Conjunctival membranes

Once inside, the bacteria are engulfed by immune cells and transported to:

  • Lymph nodes
  • Spleen
  • Reproductive organs

A bloodstream infection (bacteremia) typically develops within 1–4 weeks and may persist for months or even years. The bacteria spread to target organs, causing chronic inflammation and reproductive damage.

Clinical Signs

General Symptoms

Clinical signs are often mild or absent, which complicates early detection. When present, they may include:

  • Reduced physical condition
  • Exercise intolerance
  • Occasional fever

Reproductive Disorders

In Females

  • Late-term abortion (typically between 45–55 days of gestation)
  • Birth of weak or non-viable puppies
  • Persistent vaginal discharge
  • Infertility or repeated pregnancy loss

In Males

  • Epididymitis (inflammation of epididymis)
  • Prostatitis
  • Testicular atrophy
  • Reduced fertility or sterility

Other Clinical Manifestations

  • Enlarged lymph nodes
  • Spinal infections causing pain and lameness
  • Eye inflammation (uveitis)
  • Rare systemic complications

Diagnosis

Diagnosing canine brucellosis is complex and requires a combination of laboratory and clinical approaches.

Bacterial Culture

  • Gold standard for confirmation
  • Isolation of B. canis from blood, semen, or tissues
  • Limitations: false negatives possible due to intermittent bacteremia

Serological Tests

Common methods include:

  • Rapid agglutination tests
  • Tube agglutination tests
  • Agar gel immunodiffusion
  • ELISA (enzyme-linked immunosorbent assay)
  • Indirect immunofluorescence

Each method varies in sensitivity and specificity. False positives and negatives may occur, especially in early infection stages.

 Diagnostic Challenges

  • Variable antibody response
  • Asymptomatic carriers
  • Cross-reactivity with other bacteria

Treatment

Treatment of canine brucellosis is difficult and often unsuccessful in completely eliminating the infection.

  • The bacteria survive inside cells, limiting antibiotic effectiveness
  • Relapses are common after treatment
  • Infected animals may continue to spread the disease

Antibiotic Protocols

Combination therapies (tetracyclines with streptomycin) show partial success, but:

  • No treatment guarantees complete recovery
  • Long-term monitoring is required

Because of the risk of transmission, treated dogs are not recommended for breeding.

Control and Management in Kennels

Effective control requires strict biosecurity measures:

Essential Steps

  • Immediate isolation of infected animals
  • Routine screening of all dogs
  • Removal of positive animals from breeding programs
  • Disinfection of facilities
  • Identification of infection sources

Preventive Measures

  • Test all dogs before breeding
  • Quarantine new animals (8–12 weeks)
  • Regular health monitoring

Maintaining strict hygiene and testing protocols is critical to prevent outbreaks.

Public Health Importance

Canine brucellosis is a zoonotic disease, meaning it can be transmitted to humans, although cases are rare.

Human Infection

Occurs mainly through:

  • Direct contact with infected animals
  • Exposure to contaminated biological materials

Symptoms in Humans

  • Fever
  • Fatigue
  • Joint pain
  • Enlarged lymph nodes

Human infections are generally mild and respond well to antibiotic treatment.

Conclusion

Canine brucellosis is a globally distributed infectious disease with significant implications for animal health, breeding programs, and public health. Its silent progression, diagnostic complexity, and limited treatment options make prevention and control essential.

A comprehensive strategy combining early detection, strict biosecurity, and responsible breeding practices is crucial to limit the spread of this disease and protect both animal and human health.